$OMER
OMEROS CORP Stock $omer

$omer Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000143774924025181 Filed on August 07, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$11.32M	$13.81M	$11.26M
YoY Change	-31.05%	22.63%	-19.12%
% of Gross Profit
Research & Development	$24.08M	$45.35M	$29.64M
YoY Change	-24.1%	53.0%	26.04%
% of Gross Profit
Depreciation & Amortization	$200.0K	$200.0K	$332.0K
YoY Change	1.52%	-39.76%	73.82%
% of Gross Profit
Operating Expenses	$35.41M	$59.16M	$29.64M
YoY Change	-26.47%	99.59%	-20.83%
Operating Profit	-$35.41M	-$59.16M	-$40.90M
YoY Change	-26.47%	44.64%	9.24%
Interest Expense	$4.052M	$9.215M	$7.932M
YoY Change	-48.81%	16.17%	-260.99%
% of Operating Profit
Other Income/Expense, Net	$2.346M	$3.247M	$4.537M
YoY Change	-46.84%	-28.43%	577.16%
Pretax Income	-$37.11M	-$65.13M	-$44.29M
YoY Change	-28.15%	47.03%	6.23%
Income Tax
% Of Pretax Income
Net Earnings	-$32.23M	-$56.04M	-$37.30M
YoY Change	-14.73%	50.24%	20.91%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.56	-$0.97	-$0.59
Diluted Earnings Per Share	-$0.55	-$0.96	-$0.59
COMMON SHARES
Basic Shares Outstanding	57.95M	57.94M	62.83M
Diluted Shares Outstanding			62.84M

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$123.2M	$158.9M	$341.2M
YoY Change	-60.31%	-53.43%	178.38%
Cash & Equivalents	$1.521M	$2.120M	$6.600M
Short-Term Investments	$121.6M	$156.8M	$334.6M
Other Short-Term Assets	$6.127M	$6.273M	$7.001M
YoY Change	24.48%	-10.4%	-41.1%
Inventory
Prepaid Expenses
Receivables	$35.34M	$36.47M	$40.15M
Other Receivables	$299.0K	$1.274M	$124.0K
Total Short-Term Assets	$164.9M	$202.9M	$388.6M
YoY Change	-53.06%	-47.77%	101.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.939M	$2.034M	$22.01M
YoY Change	12.93%	-90.76%	-12.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.054M	$1.054M	$1.054M
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$148.4M	$153.4M	$138.9M
YoY Change	4.71%	10.46%	-9.19%
TOTAL ASSETS
Total Short-Term Assets	$164.9M	$202.9M	$388.6M
Total Long-Term Assets	$148.4M	$153.4M	$138.9M
Total Assets	$313.3M	$356.3M	$527.4M
YoY Change	-36.45%	-32.44%	52.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.723M	$6.502M	$9.552M
YoY Change	31.66%	-31.93%	-12.17%
Accrued Expenses	$23.25M	$27.97M	$29.79M
YoY Change	-33.31%	-6.13%	7.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$18.88M	$19.43M	$99.51M
YoY Change	-81.41%	-80.47%
Total Short-Term Liabilities	$55.62M	$59.48M	$143.5M
YoY Change	-62.21%	-58.56%	272.82%
LONG-TERM LIABILITIES
Long-Term Debt	$394.5M	$403.7M	$342.5M
YoY Change	15.84%	17.89%	8.94%
Other Long-Term Liabilities	$17.34M	$17.72M	$20.92M
YoY Change	-9.94%	-15.29%	-17.91%
Total Long-Term Liabilities	$411.9M	$421.4M	$363.4M
YoY Change	14.46%	15.98%	6.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$55.62M	$59.48M	$143.5M
Total Long-Term Liabilities	$411.9M	$421.4M	$363.4M
Total Liabilities	$467.5M	$480.9M	$506.9M
YoY Change	-7.79%	-5.13%	33.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$879.0M	-$846.8M	-$706.7M
YoY Change	18.07%	19.82%
Common Stock	$724.8M	$722.2M	$727.2M
YoY Change	-0.78%	-0.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$154.2M	-$124.6M	$20.51M
YoY Change
Total Liabilities & Shareholders Equity	$313.3M	$356.3M	$527.4M
YoY Change	-36.45%	-32.44%	52.59%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$32.23M	-$56.04M	-$37.30M
YoY Change	-14.73%	50.24%	20.91%
Depreciation, Depletion And Amortization	$200.0K	$200.0K	$332.0K
YoY Change	1.52%	-39.76%	73.82%
Cash From Operating Activities	-$32.06M	-$45.99M	-$32.34M
YoY Change	-1.8%	42.19%	66.12%
INVESTING ACTIVITIES
Capital Expenditures	$1.000K	$80.00K	$275.0K
YoY Change	-96.97%	-70.91%	-366.99%
Acquisitions
YoY Change
Other Investing Activities	$36.04M	$73.23M	$35.65M
YoY Change	-36.99%	105.41%	43.5%
Cash From Investing Activities	$36.04M	$73.15M	$35.38M
YoY Change	-36.96%	106.78%	42.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.579M	-26.88M	-260.0K
YoY Change	848.03%	10236.92%	162.63%
NET CHANGE
Cash From Operating Activities	-32.06M	-45.99M	-32.34M
Cash From Investing Activities	36.04M	73.15M	35.38M
Cash From Financing Activities	-4.579M	-26.88M	-260.0K
Net Change In Cash	-599.0K	289.0K	2.774M
YoY Change	-102.49%	-89.58%	-46.38%
FREE CASH FLOW
Cash From Operating Activities	-$32.06M	-$45.99M	-$32.34M
Capital Expenditures	$1.000K	$80.00K	$275.0K
Free Cash Flow	-$32.06M	-$46.07M	-$32.62M
YoY Change	-1.9%	41.23%	68.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001285819
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0
CY2024Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2024Q2	omer	Number Of Options To Extend Lease Term NumberOfOptionsToExtendLeaseTerm	2	pure
CY2024Q2	us-gaap	Debt Instrument Variable Interest Rate Type Extensible Enumeration DebtInstrumentVariableInterestRateTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2120000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7105000	usd
CY2024Q2	us-gaap	Short Term Investments ShortTermInvestments	156792000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	164743000	usd
CY2024Q2	omer	Royalty Receivable Current RoyaltyReceivableCurrent	29665000	usd
CY2023Q4	omer	Royalty Receivable Current RoyaltyReceivableCurrent	29373000	usd
CY2024Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	8080000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	8096000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6273000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8581000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	202930000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	217898000	usd
CY2024Q2	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	133428000	usd
CY2023Q4	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	138736000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16868000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18631000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2034000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1950000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1054000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1054000	usd
CY2024Q2	us-gaap	Assets Assets	356314000	usd
CY2023Q4	us-gaap	Assets Assets	378269000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	6502000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7712000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	27966000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31868000	usd
CY2024Q2	omer	Royalty Obligation Current RoyaltyObligationCurrent	19434000	usd
CY2023Q4	omer	Royalty Obligation Current RoyaltyObligationCurrent	8576000	usd
CY2024Q2	omer	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	5573000	usd
CY2023Q4	omer	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	5160000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	59475000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	53316000	usd
CY2024Q2	us-gaap	Senior Long Term Notes SeniorLongTermNotes	96888000	usd
CY2023Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	213155000	usd
CY2024Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	94506000	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	0	usd
CY2024Q2	omer	Royalty Liabilities Noncurrent RoyaltyLiabilitiesNoncurrent	212323000	usd
CY2023Q4	omer	Royalty Liabilities Noncurrent RoyaltyLiabilitiesNoncurrent	116550000	usd
CY2024Q2	omer	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent	15632000	usd
CY2023Q4	omer	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent	18143000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2088000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2088000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57944159
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61128597
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61128597
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	579000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	611000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	721578000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	727936000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-846755000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-753530000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-124598000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-24983000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	356314000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	378269000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45349000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29639000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	72119000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	54249000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13808000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11260000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26072000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22363000	usd
CY2024Q2	us-gaap	Costs And Expenses CostsAndExpenses	59157000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	40899000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	98191000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	76612000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-59157000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-40899000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-98191000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-76612000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	9215000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	7932000	usd
	us-gaap	Interest Expense InterestExpense	17446000	usd
	us-gaap	Interest Expense InterestExpense	15865000	usd
CY2024Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	3247000	usd
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	4537000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	6662000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	8500000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-65125000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-44294000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-108975000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-83977000	usd
CY2024Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	9084000	usd
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	7000000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	15750000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	12982000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-56041000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-37294000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-93225000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-70995000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.12
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.7
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.87
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.34
CY2024Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.15
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.11
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.27
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.21
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.97
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.6
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.13
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57944016
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62837125
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58374716
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62832991
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-24983000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	32000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11851000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2658000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-37184000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-71328000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2768000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-56041000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-124598000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	85684000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2953000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-33701000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	54936000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	97000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2771000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-37294000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	20510000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-93225000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-70995000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5426000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5724000	usd
	omer	Noncash Royalty Interest NoncashRoyaltyInterest	1806000	usd
	omer	Noncash Royalty Interest NoncashRoyaltyInterest	0	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	412000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	518000	usd
	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	-8614000	usd
	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	-7754000	usd
	omer	Interest On Contract Royalty Asset InterestOnContractRoyaltyAsset	6653000	usd
	omer	Interest On Contract Royalty Asset InterestOnContractRoyaltyAsset	4824000	usd
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	3412000	usd
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	5090000	usd
	omer	Increase Decrease In Contract Royalty Asset IncreaseDecreaseInContractRoyaltyAsset	-20283000	usd
	omer	Increase Decrease In Contract Royalty Asset IncreaseDecreaseInContractRoyaltyAsset	-19914000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1890000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1044000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-16000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-202031000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6378000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2759000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-87765000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	142198000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	626051000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	662738000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	637414000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	517057000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	138000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	275000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	11225000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-145956000	usd
	omer	Proceeds From Sale Of Future Royalties ProceedsFromSaleOfFutureRoyalties	115525000	usd
	omer	Proceeds From Sale Of Future Royalties ProceedsFromSaleOfFutureRoyalties	0	usd
	omer	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	35000	usd
	omer	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	97000	usd
	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	21179000	usd
	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	-0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11851000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
	omer	Principal Payments On Royalty Obligations PrincipalPaymentsOnRoyaltyObligations	10700000	usd
	omer	Principal Payments On Royalty Obligations PrincipalPaymentsOnRoyaltyObligations	467000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	275000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	278000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	71555000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-648000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4985000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4406000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7105000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11009000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2120000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6603000	usd
	us-gaap	Interest Paid Net InterestPaidNet	14945000	usd
	us-gaap	Interest Paid Net InterestPaidNet	15865000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-144000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3776000	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	369000	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	500000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	158900000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-87800000	usd
CY2021Q1	omer	Equity Offering Facility Maximum Aggregate Offering Amount EquityOfferingFacilityMaximumAggregateOfferingAmount	150000000	usd
CY2022Q4	omer	Percentage Of Royalty Receivable On Sale Of Product Rights PercentageOfRoyaltyReceivableOnSaleOfProductRights	0.30	pure
CY2023Q1	omer	Percentage Of Interest Earned On Outstanding Contract Royalty Asset PercentageOfInterestEarnedOnOutstandingContractRoyaltyAsset	0.11	pure
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9799386
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17302417
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10787625
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17245683
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	2500000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	4200000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	5300000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	7600000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	156792000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-5000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	156787000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale And Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	157846000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-5000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	157841000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	164743000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	19000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	164762000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	165797000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	19000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	165816000	usd
CY2024Q2	omer	Royalty Receivable Current RoyaltyReceivableCurrent	29665000	usd
CY2023Q4	omer	Royalty Receivable Current RoyaltyReceivableCurrent	29373000	usd
CY2024Q2	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	133428000	usd
CY2023Q4	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	138736000	usd
CY2024Q2	omer	Contract Royalty Asset ContractRoyaltyAsset	163093000	usd
CY2023Q4	omer	Contract Royalty Asset ContractRoyaltyAsset	168109000	usd
CY2024Q2	omer	Royalty Receivable RoyaltyReceivable	6806000	usd
CY2023Q4	omer	Royalty Receivable RoyaltyReceivable	6724000	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1274000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1372000	usd
CY2024Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	8080000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	8096000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12569000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12191000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10535000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10241000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2034000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1950000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	200000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	300000	usd
	us-gaap	Depreciation Depreciation	400000	usd
	us-gaap	Depreciation Depreciation	500000	usd
CY2024Q2	omer	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	8091000	usd
CY2023Q4	omer	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	10168000	usd
CY2024Q2	omer	Accrued Contract Research Costs AccruedContractResearchCosts	7104000	usd
CY2023Q4	omer	Accrued Contract Research Costs AccruedContractResearchCosts	6223000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5556000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7380000	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3035000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3539000	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	2641000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4242000	usd
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1538000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	316000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	27966000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	31868000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	20000000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	97862000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	47077000	usd
CY2024Q2	omer	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	0	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	164939000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	26455000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	191394000	usd
CY2024Q2	omer	Royalty Obligation Principal Payments Due Next Twelve Months RoyaltyObligationPrincipalPaymentsDueNextTwelveMonths	9292000	usd
CY2024Q2	omer	Royalty Obligation Interest Payments Due Next Twelve Months RoyaltyObligationInterestPaymentsDueNextTwelveMonths	11058000	usd
CY2024Q2	omer	Royalty Obligation Payments Due Next Twelve Months RoyaltyObligationPaymentsDueNextTwelveMonths	20350000	usd
CY2024Q2	omer	Royalty Obligation Principal Payments Due Year Two RoyaltyObligationPrincipalPaymentsDueYearTwo	20995000	usd
CY2024Q2	omer	Royalty Obligation Interest Payments Due Year Two RoyaltyObligationInterestPaymentsDueYearTwo	20667000	usd
CY2024Q2	omer	Royalty Obligation Payments Due Year Two RoyaltyObligationPaymentsDueYearTwo	41662000	usd
CY2024Q2	omer	Royalty Obligation Principal Payments Due Year Three RoyaltyObligationPrincipalPaymentsDueYearThree	23996000	usd
CY2024Q2	omer	Royalty Obligation Interest Payments Due Year Three RoyaltyObligationInterestPaymentsDueYearThree	18500000	usd
CY2024Q2	omer	Royalty Obligation Payments Due Year Three RoyaltyObligationPaymentsDueYearThree	42496000	usd
CY2024Q2	omer	Royalty Obligation Principal Payments Due Year Four RoyaltyObligationPrincipalPaymentsDueYearFour	27318000	usd
CY2024Q2	omer	Royalty Obligation Interest Payments Due Year Four RoyaltyObligationInterestPaymentsDueYearFour	16027000	usd
CY2024Q2	omer	Royalty Obligation Payments Due Year Four RoyaltyObligationPaymentsDueYearFour	43345000	usd
CY2024Q2	omer	Royalty Obligation Principal Payments Due Year Five RoyaltyObligationPrincipalPaymentsDueYearFive	30995000	usd
CY2024Q2	omer	Royalty Obligation Interest Payments Due Year Five RoyaltyObligationInterestPaymentsDueYearFive	13217000	usd
CY2024Q2	omer	Royalty Obligation Payments Due Year Five RoyaltyObligationPaymentsDueYearFive	44212000	usd
CY2024Q2	omer	Royalty Obligation Principal Payments Due After Year Five RoyaltyObligationPrincipalPaymentsDueAfterYearFive	119161000	usd
CY2024Q2	omer	Royalty Obligation Interest Payments Due After Year Five RoyaltyObligationInterestPaymentsDueAfterYearFive	18852000	usd
CY2024Q2	omer	Royalty Obligation Payments Due After Year Five RoyaltyObligationPaymentsDueAfterYearFive	138013000	usd
CY2024Q2	omer	Royalty Obligation Principal Payments Due RoyaltyObligationPrincipalPaymentsDue	231757000	usd
CY2024Q2	omer	Royalty Obligation Interest Payments Due RoyaltyObligationInterestPaymentsDue	98321000	usd
CY2024Q2	omer	Royalty Obligation Payments Due RoyaltyObligationPaymentsDue	330078000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1100000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1606000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1616000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	3211000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	3249000	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	149000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	271000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	295000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	389000	usd
CY2024Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	40000	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	41000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	97000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	92000	usd
CY2024Q2	us-gaap	Variable Lease Cost VariableLeaseCost	882000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	757000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	1798000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	1547000	usd
CY2024Q2	us-gaap	Sublease Income SubleaseIncome	385000	usd
CY2023Q2	us-gaap	Sublease Income SubleaseIncome	375000	usd
	us-gaap	Sublease Income SubleaseIncome	774000	usd
	us-gaap	Sublease Income SubleaseIncome	750000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	2292000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	2310000	usd
	us-gaap	Lease Cost LeaseCost	4627000	usd
	us-gaap	Lease Cost LeaseCost	4527000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3630000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3568000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	361000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	336000	usd
CY2024Q2	omer	Longterm Purchase Commitment Termination Fee LongtermPurchaseCommitmentTerminationFee	7900000	usd
CY2021Q1	omer	Equity Offering Facility Maximum Aggregate Offering Amount EquityOfferingFacilityMaximumAggregateOfferingAmount	150000000	usd
CY2023Q4	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	5000000
	omer	Stock Repurchased And Retired Average Price Per Share StockRepurchasedAndRetiredAveragePricePerShare	3.3
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	3200000
CY2024Q1	omer	Stock Repurchased And Retired Average Price Per Share StockRepurchasedAndRetiredAveragePricePerShare	3.71
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11900000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2768000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2771000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5426000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5724000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15255154
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.5
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3072900
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.1
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	10803
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.32
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	327751
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.83
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17989500
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.46
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M12D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6863000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	17307104
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	8.64
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y1M6D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	6280000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11556891
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.03
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y7M6D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1282000	usd
CY2024Q2	us-gaap	Share Price SharePrice	4.06
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	6100000

Files In Submission

Name	View Source	Status
0001437749-24-025181-index-headers.html	Edgar Link	pending
0001437749-24-025181-index.html	Edgar Link	pending
0001437749-24-025181.txt	Edgar Link	pending
0001437749-24-025181-xbrl.zip	Edgar Link	pending
ex_679184.htm	Edgar Link	pending
ex_679185.htm	Edgar Link	pending
ex_679186.htm	Edgar Link	pending
ex_679187.htm	Edgar Link	pending
ex_707092.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
omer-20240630.xsd	Edgar Link	pending
omer20240630_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
omer-20240630_cal.xml	Edgar Link	unprocessable
omer-20240630_def.xml	Edgar Link	unprocessable
omer-20240630_lab.xml	Edgar Link	unprocessable
omer-20240630_pre.xml	Edgar Link	unprocessable
omer20240630_10q_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OMER
OMEROS CORP Stock $omer

2024 Q3 Form 10-Q Financial Statement

#000143774924025181 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMER OMEROS CORP Stock $omer

2024 Q3 Form 10-Q Financial Statement

#000143774924025181 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMER
OMEROS CORP Stock $omer